Showing 201-220 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
Cochrane Systematic Reviews, 7-Nov-2008
Homeopathy is one form of complementary/alternative medicine which is promoted as being a safe and effective form of treatment for children and adults. Within the UK homeopathy use is estimated at 1.9% of the adult population (Thomas 2004), and around 11%
- Homeopathy for dementia
Cochrane Systematic Reviews, 20-Jan-2003
Dementia is a common illness in older people and has major implications for individuals with the disease, their carers and society. A meta-analysis of population based studies in Europe found the prevalence of dementia in individuals over 65 to be 6.4%. H
- Hormone replacement therapy for cognitive function in postmenopausal women
Cochrane Systematic Reviews, 23-Jan-2008
As estrogens have been found in animal models to be associated with the maintenance and protection of brain structures, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by medication could be protective agains
- Hormone replacement therapy to maintain cognitive function in women with dementia
Cochrane Systematic Reviews, 21-Jan-2009
As estrogens have been shown to have several potentially beneficial effects on the central nervous system, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by means of estrogen replacement therapy (ERT) could
- Huperzine A for Alzheimer's disease
Cochrane Systematic Reviews, 23-Apr-2008
Alzheimer's disease (AD) has become a major public health problem around the world due to its increasing prevalence, long duration, caregiver burden, and high financial cost of care. The degeneration of acetylcholine-containing neurons in the basal forebr
- Huperzine A for vascular dementia
Cochrane Systematic Reviews, 15-Apr-2009
Huperzine A, a form of herbal medicine, has been considered as an alternative treatment for vascular dementia (VaD) in China.
- Hydergine for dementia
Cochrane Systematic Reviews, 24-Jul-2000
Currently hydergine is used almost exclusively for treating patients with either dementia, or 'age-related' cognitive symptoms. Since the early 1980s there have been over a dozen more clinical trials, yet hydergine's efficacy remains uncertain. Although p
- Hydromorphone for acute and chronic pain
Cochrane Systematic Reviews, 25-Oct-2013
This is an updated version of the original review, published in Issue 1, 2002. Some patients with severe cancer pain either do not achieve adequate analgesia with morphine, or suffer intolerable toxicity. For these patients alternatives such as hydromorph
- Hyperbaric oxygen therapy for Bell's palsy
Cochrane Systematic Reviews, 15-Feb-2012
Bell's palsy is an idiopathic, acute unilateral facial weakness that evolves rapidly and is maximal within two days. Moderate ear discomfort, sensitivity to sound and reduced tearing may occur.
- Hyperbaric oxygen therapy for multiple sclerosis
Cochrane Systematic Reviews, 26-Jan-2004
Multiple Sclerosis (MS) is a chronic, recurrent and progressive illness with no cure. On the basis of speculative pathophysiology, it has been suggested that Hyperbaric Oxygen Therapy (HBOT) may slow or reverse the progress of the disease.
- Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
Cochrane Systematic Reviews, 19-Nov-2012
Traumatic brain injury is a common health problem with significant effect on quality of life. Each year in the USA approximately 0.56% of the population suffer a head injury, with a case fatality rate of about 40% for severe injuries. These account for a
- Hyperventilation therapy for acute traumatic brain injury
Cochrane Systematic Reviews, 20-Oct-1997
Because hyperventilation is often associated with a rapid fall in intracranial pressure, it has been assumed to be effective in the treatment of severe head injury. Hyperventilation reduces raised intracranial pressure by causing cerebral vasoconstriction
- Hypothermia for traumatic brain injury
Cochrane Systematic Reviews, 21-Sep-2017
Hypothermia has been used in the treatment of brain injury for many years. Encouraging results from small trials and laboratory studies led to renewed interest in the area and some larger trials.
- Ibuprofen for Alzheimer's disease
Cochrane Systematic Reviews, 13-May-2008
Non-steroidal antiinflammatory drugs such as ibuprofen may have a role in the treatment of conditions characterized by inflammatory processes. Ibuprofen may attenuate the effects of modulators of inflammation that have been implicated in the pathogenesis
- Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
Cochrane Systematic Reviews, 9-Dec-2016
Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co-ordination and unsteadiness. These adverse events often occur during peaks in drug plasma c
- Immunoglobulin for multifocal motor neuropathy
Cochrane Systematic Reviews, 11-Jan-2022
Multifocal motor neuropathy (MMN) is a rare, probably immune-mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs with no objective loss of sensation. It may cause prolonged periods of disability. Treatme
- Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 8-May-2017
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and numbness. It is probably caused by an autoimmune process. Immunosuppressive or immunomodulatory drugs would be ex
- Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
Cochrane Systematic Reviews, 4-Mar-2015
Multifocal motor neuropathy (MMN) is characterised by progressive, predominantly distal, asymmetrical limb weakness and usually multiple partial motor nerve conduction blocks. Intravenous immunoglobulin (IVIg) is beneficial but the role of immunosuppressi
- Immunosuppressive agents for myasthenia gravis
Cochrane Systematic Reviews, 2-Nov-2008
The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.
- Immunosuppressive treatment for non-systemic vasculitic neuropathy
Cochrane Systematic Reviews, 3-Apr-2013
Non-systemic vasculitic neuropathy is a rare disabling disease that usually has a subacute onset of progressive or relapsing-remitting sensory or sensorimotor deficits. Asymmetry, pain and weakness are key features. The diagnosis can only be made by exclu
